世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

睡眠時無呼吸装置の世界市場展望、2028年


Global Sleep Apnea Devices Market Outlook, 2028

睡眠時無呼吸症候群は、世界中で数百万人が罹患している、一般的でありながら診断されないことの多い睡眠障害である。睡眠中の呼吸の休止や浅い呼吸を特徴とする睡眠時無呼吸症候群は、全身の健康と幸福に深刻な... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Bonafide Research & Marketing Pvt. Ltd.
ボナファイドリサーチ 		2023年11月30日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		165 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

睡眠時無呼吸症候群は、世界中で数百万人が罹患している、一般的でありながら診断されないことの多い睡眠障害である。睡眠中の呼吸の休止や浅い呼吸を特徴とする睡眠時無呼吸症候群は、全身の健康と幸福に深刻な影響を及ぼす可能性があります。睡眠時無呼吸症候群は、睡眠中の呼吸の中断を特徴とし、世界中で数百万人に影響を及ぼしている一般的な睡眠障害である。全米睡眠財団によると、米国内はもとより、5,000万～7,000万人が継続的な睡眠障害を抱えているという。最も一般的な睡眠障害は不眠症で、入眠障害や睡眠維持障害を伴う。幸いなことに、医療技術の進歩により、睡眠時無呼吸症候群の管理・治療を目的とした様々な機器が開発されている。睡眠時無呼吸症候群の認知度の向上、技術の進歩、そして全身の健康にとって質の高い睡眠が重要であるという理解の高まりにより、睡眠時無呼吸症候群治療器産業は近年目覚ましい成長を遂げている。睡眠時無呼吸症候群の認知度が高まるにつれ、睡眠の質を向上させ、健康全般を改善するための効果的なソリューションに対する需要も高まっている。睡眠時無呼吸装置に対する消費者の状況は、多様な嗜好、ニーズ、期待を反映している。睡眠時無呼吸症候群に対する認識が高まるにつれ、消費者は利用可能な機器に関する情報を求めるようになった。消費者は、機器の種類、機能、潜在的な利点に関する知識を備えていれば、十分な情報を得た上で意思決定を行う可能性が高くなる。デジタル時代は情報へのアクセスを容易にした。消費者は購入前に、オンライン・プラットフォーム、フォーラム、評判の高い健康ウェブサイトなどを利用して、睡眠時無呼吸症候群治療器に関する洞察を深めたり、レビューを読んだり、知識を得たりすることが多い。マスクの快適性は、PAP（Positive Airway Pressure：陽圧呼吸）装置を使用する消費者にとって重要な検討事項である。メーカーは、ユーザーの快適性を高め、閉所恐怖感を軽減するために、さまざまな形状、サイズ、素材のマスクを設計することで対応している。消費者の嗜好もまた、より静かな機器に傾いている。メーカー各社は騒音レベルを低減した睡眠時無呼吸装置の開発に努め、パートナーと睡眠空間を共有する個人に共通する懸念に対処している。消費者の動向は、持ち運びや旅行に便利な睡眠時無呼吸症候群治療器への嗜好の高まりを反映している。コンパクトなデザインと軽量素材は、アクティブなライフスタイルを送る人や頻繁に旅行する人のニーズに応えるものである。消費者は、日常生活にシームレスに溶け込み、最小限の調整とメンテナンスで済む装置を好む。このような統合はコンプライアンスを高め、治療効果に貢献する。

Bonafide Research社の調査レポート「睡眠時無呼吸装置の世界市場展望、2028年」によると、同市場は2022年の84億7000万米ドルから2028年には120億米ドルを超えると予測されている。同市場は2023-28年までに年平均成長率7%以上で成長すると予測されている。睡眠時無呼吸症候群の有病率の増加、老年人口の増加、肥満と高血圧の有病率の増加、新興国における患者層の意識の高まりが市場を牽引する主な要因である。高齢化は、睡眠時無呼吸装置市場の成長を促す主要な要素である。特に高齢者はこの病気にかかりやすい。さらに、睡眠障害は治療が最も困難な病状のひとつであり、人生のある時点で3人に1人が罹患することが明らかになっている。睡眠時無呼吸症候群は、しばしば誤診され、治療されないままになっている、致命的な睡眠障害の可能性がある。しかし、さまざまな政府プログラムがOSA患者を支援している。例えば米国では、米国睡眠時無呼吸症候群協会（ASAA）が睡眠時無呼吸症候群に対する認識を高め、治療の改善に努め、睡眠時無呼吸症候群患者の利益のために戦う非営利団体である。さらに、革新的な商品に対する需要の高まりに対応するために、メーカーが製品のリリースを増やしていることも、市場の成長を後押しすると考えられる。例えば2021年8月、ResMedはPhilipsのCPAPリコールで空いた穴を埋めるべく、新しい睡眠時無呼吸症候群治療器を発表した。同様に、閉塞性睡眠時無呼吸症候群の口腔内装置療法を提供する在宅ケアプロバイダーGoPAPfreeは、2021年2月に、CPAP療法に代わる非常に効果的でより便利なO2Vent Optimaを発表した。さらに、米国睡眠協会やドイツ睡眠学会など数多くの政府機関が、複雑で慢性的な睡眠障害に苦しむ人々の生活の質を向上させるための啓発キャンペーンを開始している。消費者が睡眠問題とその健康への影響についてより多くの情報を得るにつれて、早期診断への欲求が市場収益を押し上げると思われる。高齢者や肥満者の増加に伴い、慢性不眠症はより一般的になりつつある。さらに、メランコリー、慢性疾患、不安に悩む人の増加が、睡眠時無呼吸装置の需要を押し上げている。さらに、このような装置の開発は、低開発国における不眠症の負担が高い地域をターゲットにするのに役立つだろう。

地域別では、現在北米が睡眠時無呼吸装置の市場を支配しており、予測期間中もこの傾向が続くと予想される。

ライフスタイルの変化、可処分所得の増加、有名プレイヤーの存在、肥満人口の増加、呼吸器疾患の頻度増加、OSAの認知度向上、政府の好意的な取り組みなどが成長を促進する主な理由である。Philips Respironics、Somnetics International Inc.、ResMedが北米の主要企業である。これらの企業は北米全域で大きな存在感を示し、供給・販売体制も確立している。悲しみや不安など多くの基礎疾患による睡眠時無呼吸症候群の有病率の上昇、技術の向上、研究による製品導入の増加、さらにCOVID-19のロックダウンがこの地域のアメリカ人に与える影響の大きさなどが、市場を牽引すると予想される。さらに、睡眠時無呼吸症候群の高リスク因子である肥満や心臓病など、その他の健康問題の有病率の増加が市場成長に寄与すると予測されています。さらに、さまざまな政府機関が、消費者や医療専門家に健康的な睡眠習慣を教育するための啓発キャンペーンを展開している。さらに、市場の大手企業は、技術的に効率的で効果的、かつ使いやすいガジェットの開発に多額の投資を行っている。生活習慣の変化によって、さまざまな睡眠障害が頻繁に発生することがわかっている。さらに、タバコ、カフェイン、アルコールの摂取量の増加は、個人の睡眠パターンに影響を与える。さらに、同地域における睡眠ケアセンターの増加が市場拡大の原動力となりそうだ。例えば、GoPAPfreeは、2021年2月9日に新しい個別化口腔アプライアンス治療装置の発売を発表し、閉塞性睡眠時無呼吸症候群のCPAP療法に代わる効率的で許容可能な代替療法を自宅での整形と実施で提供する。北米にはCarilion Clinic、Adam Moscovitch、Florida Lung, Asthma, and Sleep Specialists、Oregon Sleep Associates、Sound Sleep Healthなど様々なセンターが存在し、この地域の成長をさらに後押しするだろう。

製品タイプ別では、治療機器分野が市場貢献度が最も高く、予測期間中に大きな成長率が見込まれる。

予測期間中、治療機器セグメントが収益の大半を占めると予想される。これは、CPAP療法を含め、睡眠クリニックで治療を受ける患者数の増加や、患者にとって治療のセットアップや夜間の使用を容易にする一方で、医師がより効果的にケアを提供できるよう支援することを目的とした新しいデジタル技術の開発によるものである。例えば、2021年8月16日、デジタルヘルスと睡眠時無呼吸症候群治療の世界的イノベーターであるResMed社は、閉塞性睡眠時無呼吸症候群を管理・治療するための治療の確立と維持において、世界中の何億人もの睡眠時無呼吸症候群患者を支援するために設計された同社の次世代気道陽圧（PAP）デバイスであるAirSense 11を発売した。未診断の人口が多いことに加え、これらの患者の意識が高まっているため、先進国でも発展途上国でも診断率が高くなっている。そのため、これらの国では睡眠ポリグラフ検査装置などの診断装置の需要が高まっている。治療用デバイスには、気道陽圧（PAP）デバイス、口腔デバイス、鼻腔デバイス、あごひもなどが含まれる。2019年の収益シェアでは、治療機器カテゴリーが市場全体を支配している。SA装置のメーカーは、支持療法に対する患者のアドヒアランスの向上、技術的に改良された装置の入手可能性の増加、地方自治体による取り組み件数の増加、これらの疾患に対する認知度の向上などの要因の結果として、収益性の高い可能性を期待する必要がある。このため、予測期間を通じて治療機器カテゴリの拡大が見込まれる。しかし、睡眠時無呼吸症候群の有病率の増加や、疾病管理のためのCPAP（Continuous Positive Airway Pressure：持続陽圧呼吸）装置の使用増加により、睡眠時無呼吸症候群用マスクの使用は拡大している。鼻用マスク、鼻ピローマスク、フルフェイスマスクなど、さまざまなSAマスクがある。CPAP（持続陽圧）マスクは、SA患者をCPAPマシンに接続するために使用されます。どのCPAPマスクも仕組みは同じで、CPAP装置からホースを介して患者の気道に空気を送ります。これにより、睡眠中に気道が開いた状態を保つことで、閉塞性睡眠時無呼吸症候群を回避します。睡眠時無呼吸症候群用マスクの使用は、睡眠時無呼吸症候群用装置の技術開発に影響されると予想される。

在宅医療に関連する意識の広がりとともに、ユーザーフレンドリーな在宅医療用睡眠時無呼吸デバイスの採用・導入が加速していることから、在宅医療環境・個人セグメントが2028年までに世界市場を支配すると予想される。

予測期間中、在宅ケア環境における自己管理のための睡眠時無呼吸診断・治療デバイスの使用増加が、この市場セグメントの成長を後押しすると予想される。在宅ケアの睡眠診断技術は、軽度から重度の睡眠時無呼吸症候群の人に正確である。一般的な家庭の雰囲気の中で使用されるため、邪魔にならないと考えられている。市場サプライヤーは、在宅睡眠時無呼吸診断技術の開発に投資している。主要な市場参入企業による投資の増加により、予測期間中、在宅ケア設定/個人部門はより大きな収益シェアを獲得する可能性が高い。例えば、2022年10月3日、英国の医療機器企業であるAcurable社は、Kibo Venturesが主導する1080万米ドルのシリーズA資金調達ラウンドを発表した。同ファンドはMundi Ventures、Comprador Holdings、Kindred Capitalが共同主導した。この資金調達は、閉塞性睡眠時無呼吸症候群の検出とモニタリングのための同社初の家庭用睡眠検査装置であるAcuPebble SA100の国際的な拡大を加速させるために使用される。市場参加者は、病気の治療を受けている患者の間で、家庭用の斬新で携帯可能なガジェットの導入に力を注いでいる。これは、特に米国、英国、ドイツ、日本などの国々でOSAの在宅治療に対する嗜好が高まっていることと相まって、在宅医療やその他の環境におけるこれらの機器の需要を押し上げている。例えば、睡眠時無呼吸症候群の口腔内装置療法の在宅ケアプロバイダーであるGoPAPfree社は、2021年2月にO2Vent OptimaIを発売しており、これはCPAP療法に代わる非常に効果的な治療法であり、在宅で活用することができる。これは、これらの装置の在宅使用を促進する十分な償還規制とともに、市場拡大をさらに促進している。

市場牽引要因

- 睡眠時無呼吸症候群の有病率の増加：世界的な睡眠時無呼吸症候群の有病率の上昇は、睡眠時無呼吸症候群治療器市場の重要な促進要因である。肥満、座りがちなライフスタイル、高齢化などの要因が、睡眠時無呼吸症候群の罹患率上昇に寄与している。医療従事者だけでなく一般住民の間でも睡眠障害に対する意識が高まるにつれ、睡眠時無呼吸症候群の診断・治療機器に対する需要も高まると予想される。

- 睡眠時無呼吸装置の技術的進歩：技術の進歩により、より効率的で使い勝手のよい睡眠時無呼吸症候群治療装置が開発されている。小型でウェアラブルなデバイスの使用、マスク技術の向上、遠隔モニタリングのためのデータ接続機能の搭載など、デバイス設計の革新は患者のコンプライアンスと治療成績の向上に寄与している。医療提供者がより効果的で患者に優しいソリューションを求めているため、技術の進歩が市場の成長を促進する可能性が高い。

市場の課題

- 限られた患者のコンプライアンス：睡眠時無呼吸症候群の一般的な治療法である持続陽圧呼吸療法（CPAP）は、患者によっては不快に感じ、アドヒアランスの低下につながることがあります。患者の快適性、教育、サポートに関する問題に対処することは、コンプライアンス率を向上させ、睡眠時無呼吸症候群の治療効果を確保する上で極めて重要である。

- 睡眠時無呼吸装置の高額な費用：睡眠時無呼吸症候群治療器、特に高度な機能を備えた先進的な治療器のコストは、普及の障害となる可能性がある。特に医療資源が限られている地域では、手頃な価格が大きな懸念材料となる。製造業者と医療提供者は、先端技術の開発と、これらの機器をより多くの患者にとって利用しやすく費用対効果の高いものにする必要性とのバランスをとるという課題に直面している。

市場動向

- 在宅睡眠検査（HST）：従来の検査室での睡眠検査に代わるものとして、自宅での睡眠検査を求める傾向が高まっている。在宅睡眠検査は、より便利で費用対効果の高い睡眠時無呼吸症候群の診断を可能にし、患者の検査へのアクセス向上に貢献している。この傾向は、医療の分散化と患者中心のソリューションに向けた幅広い動きと一致している。

- 人工知能（AI）とデータ分析の統合：睡眠時無呼吸装置におけるAIとデータ分析の統合は注目すべき傾向である。スマートデバイスは、睡眠パターンと治療アドヒアランスに関連するデータを収集・分析し、患者と医療提供者の双方に貴重な洞察を提供することができる。AIアルゴリズムは治療計画の個別化を強化し、より効果的な介入と患者の転帰改善につながる。

- 遠隔医療と遠隔モニタリング：遠隔医療と遠隔患者モニタリングの傾向は、特に睡眠時無呼吸症候群の文脈で加速している。遠隔医療を利用すれば、バーチャルな診察、睡眠パターンの遠隔モニタリング、治療計画の調整などを、頻繁に対面することなく行うことができる。この傾向は、特に医療施設へのアクセスが困難な状況で顕著になってきている。

Covid-19の影響

パンデミックは世界のサプライチェーンを混乱させ、睡眠時無呼吸装置を含む医療機器の製造と流通に影響を及ぼしている。ロックダウン、渡航制限、医療資源に対する需要の変化により、これらの機器の製造と配送に困難が生じた。パンデミックの影響により、睡眠関連疾患を含む緊急性のない健康問題に対して、個人が受診を先延ばしにしたり、受診を避けたりしている。パンデミックの最盛期には患者が特定されず適切な治療法が処方されなかったため、このような診断・治療の遅れは睡眠時無呼吸症候群治療器の需要に影響を与える可能性がある。パンデミックは、様々な医療分野で遠隔医療や遠隔モニタリング・ソリューションの採用を加速させている。特に睡眠時無呼吸症候群の患者は、医療施設への直接訪問を避けるために、バーチャル診察や遠隔モニタリングの選択肢を求めている。この傾向は、接続機能が強化された睡眠時無呼吸装置の開発と採用に影響を与える可能性がある。パンデミックに起因する経済的課題は、医療サービスや医療機器を購入する個人の能力に影響を及ぼしている。この経済的影響は睡眠時無呼吸症候群患者の購入意思決定に影響を与える可能性があり、異なるタイプの機器に対する需要のシフトや、より費用対効果の高いソリューションの嗜好につながる可能性がある。COVID-19の大流行時に呼吸器の健康に対する意識が高まったことで、睡眠に関連する呼吸障害への関心が高まった。医療提供者も患者も同様に睡眠時無呼吸症候群の症状に敏感になっており、医療サービスがより正常な状態に戻れば、診断と治療が増加する可能性がある。パンデミック（世界的大流行）期にリモートワークが広く普及したことにより、ワークスケジュールやライフスタイルの変化が睡眠パターンに影響を与えた。こうした変化は、睡眠時無呼吸症候群を含む睡眠障害の有病率、ひいては診断・治療機器の需要に影響を与える可能性がある。

競合他社の状況

主要企業は競争力を高め、事業領域を拡大するため、常に革新的な製品開発戦略に注力している。各社は、提供する製品を拡大し、拡大する顧客層にサービスを提供するために、M&Aやパートナーシップ戦略を考案している。例えば、2021年2月、Nyxoah SAとVanderbilt Universityは、OSA治療のための革新的な神経刺激ソリューションを開発するための戦略的パートナーシップを締結した。この市場で著名な企業には、診断・治療用睡眠時無呼吸装置の老舗で財務的に安定したメーカーが含まれる。これらの睡眠時無呼吸症候群関連企業は、数年前からこの市場で事業を展開しており、多様な製品ポートフォリオ、最先端技術、強力なグローバル販売・マーケティングネットワークを有している。この市場で著名な睡眠時無呼吸症候群メーカーには、ResMed（米国）、Koninklijke Philips N.V.（オランダ）、Fisher & Paykel Healthcare（ニュージーランド）などがある。

主要開発

- 2022年11月、ResMedとAlphabetのライフサイエンス部門であるVerilyは、雇用者と医療提供者が複雑な睡眠障害のリスクを抱える集団を特定するのを支援するエンドツーエンドのソリューションであるPrimasunの設立を発表した。

- 2022年10月、最も世界的に研究されているカスタム口腔内装置のメーカーであるAirway Management社は、いびきと軽度から中等度の閉塞性睡眠時無呼吸症候群の患者を治療するために設計された、ラボ製の高級口腔内装置であるflexTAPの発売を発表。

- 2022年9月、GEヘルスケアとWayraは7社のヘルステック新興企業と提携し、欧州、中東、アフリカ全域でヘルスケアのデジタルトランスフォーメーションを加速。

- 2022年2月、ラジオメーター・パシフィック社との提携により、TCM5 Flex経皮モニタがコンピュメディクスの包括的な睡眠診断製品ラインに加わった。Compumedics は現在、オーストラリアとニュージーランドにおける TCM 5 Flex の正規販売代理店です。

- 2022年、フィッシャー＆ペイケルヘルスケア（ニュージーランド）は、閉塞性睡眠時無呼吸症候群（OSA）治療用のコンパクトなフルフェイスマスク、エヴォラ・フルを米国で発売した。

本レポートで検討しているもの

- 地域世界
- 歴史的な年2017
- 基準年2022
- 推定年2023
- 予測年2028

本レポートでカバーされている側面

- 睡眠時無呼吸症候群デバイスの世界市場：その価値と予測、セグメントとともに
- 地域別・国別の睡眠時無呼吸症候群デバイス市場分析
- 様々な促進要因と課題
- 進行中のトレンドと開発
- トッププロファイル企業
- 戦略的提言

レポート対象地域と国

- 北米（米国、カナダ、メキシコ）
- ヨーロッパ（ドイツ、イギリス、フランス、スペイン、イタリア、ロシア）
- アジア太平洋（中国、日本、インド、オーストラリア、韓国）
- 南米（ブラジル、アルゼンチン、コロンビア）
- 中東・アフリカ（UAE、サウジアラビア、南アフリカ）

製品別

- 気道陽圧（PAP）装置
- 適応サーボ換気（ASV）
- 気道確保システム
- 酸素供給製品
- 口腔器具
- その他

エンドユーザー別

- 在宅介護施設・個人
- 睡眠研究所・病院



レポートのアプローチ

本レポートは、一次調査と二次調査を組み合わせたアプローチで構成されている。まず、市場を把握し、市場に参入している企業をリストアップするために二次調査を行った。二次調査は、プレスリリースや企業の年次報告書などの第三者情報源、政府が作成した報告書やデータベースの分析で構成されている。二次情報源からデータを収集した後、一次調査は、市場がどのように機能しているかについて主要プレーヤーに電話インタビューを行い、市場のディーラーや流通業者と取引コールを行うことによって実施された。その後、消費者を地域別、階層別、年齢層別、性別に均等にセグメンテーションし、消費者への一次調査を開始した。一次データを入手した後は、二次ソースから入手した詳細の検証を開始した。

対象読者

本レポートは、業界コンサルタント、メーカー、サプライヤー、睡眠時無呼吸症候群治療装置業界関連団体・組織、政府機関、その他関係者が市場中心の戦略を調整する際に役立ちます。また、マーケティングやプレゼンテーションだけでなく、業界に関する競合知識を高めることもできます。






""
"
***注：注文確認後、報告書をお届けするまでに48時間（2営業日）かかります。

ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Covid-19 Effect
2.5. Supply chain Analysis
2.6. Policy & Regulatory Framework
2.7. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Sleep Apnea Therapeutic Devices Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Product
6.5. Market Size and Forecast, By End User
7. North America Sleep Apnea Therapeutic Devices Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Product
7.4. Market Size and Forecast, By End User
7.5. United States Sleep Apnea Therapeutic Devices Market Outlook
7.5.1. Market Size By Value
7.5.2. Market Size and Forecast By Product
7.5.3. Market Size and Forecast By End User
7.6. Canada Sleep Apnea Therapeutic Devices Market Outlook
7.6.1. Market Size By Value
7.6.2. Market Size and Forecast By Product
7.6.3. Market Size and Forecast By End User
7.7. Mexico Sleep Apnea Therapeutic Devices Market Outlook
7.7.1. Market Size By Value
7.7.2. Market Size and Forecast By Product
7.7.3. Market Size and Forecast By End User
8. Europe Sleep Apnea Therapeutic Devices Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Product
8.4. Market Size and Forecast, By End User
8.5. Germany Sleep Apnea Therapeutic Devices Market Outlook
8.5.1. Market Size By Value
8.5.2. Market Size and Forecast By Product
8.5.3. Market Size and Forecast By End User
8.6. United Kingdom Sleep Apnea Therapeutic Devices Market Outlook
8.6.1. Market Size By Value
8.6.2. Market Size and Forecast By Product
8.6.3. Market Size and Forecast By End User
8.7. France Sleep Apnea Therapeutic Devices Market Outlook
8.7.1. Market Size By Value
8.7.2. Market Size and Forecast By Product
8.7.3. Market Size and Forecast By End User
8.8. Italy Sleep Apnea Therapeutic Devices Market Outlook
8.8.1. Market Size By Value
8.8.2. Market Size and Forecast By Product
8.8.3. Market Size and Forecast By End User
8.9. Spain Sleep Apnea Therapeutic Devices Market Outlook
8.9.1. Market Size By Value
8.9.2. Market Size and Forecast By Product
8.9.3. Market Size and Forecast By End User
8.10. Russia Sleep Apnea Therapeutic Devices Market Outlook
8.10.1. Market Size By Value
8.10.2. Market Size and Forecast By Product
8.10.3. Market Size and Forecast By End User
9. Asia-Pacific Sleep Apnea Therapeutic Devices Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Product
9.4. Market Size and Forecast, By End User
9.5. China Sleep Apnea Therapeutic Devices Market Outlook
9.5.1. Market Size By Value
9.5.2. Market Size and Forecast By Product
9.5.3. Market Size and Forecast By End User
9.6. Japan Sleep Apnea Therapeutic Devices Market Outlook
9.6.1. Market Size By Value
9.6.2. Market Size and Forecast By Product
9.6.3. Market Size and Forecast By End User
9.7. India Sleep Apnea Therapeutic Devices Market Outlook
9.7.1. Market Size By Value
9.7.2. Market Size and Forecast By Product
9.7.3. Market Size and Forecast By End User
9.8. Australia Sleep Apnea Therapeutic Devices Market Outlook
9.8.1. Market Size By Value
9.8.2. Market Size and Forecast By Product
9.8.3. Market Size and Forecast By End User
9.9. South Korea Sleep Apnea Therapeutic Devices Market Outlook
9.9.1. Market Size By Value
9.9.2. Market Size and Forecast By Product
9.9.3. Market Size and Forecast By End User
10. South America Sleep Apnea Therapeutic Devices Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Product
10.4. Market Size and Forecast, By End User
10.5. Brazil Sleep Apnea Therapeutic Devices Market Outlook
10.5.1. Market Size By Value
10.5.2. Market Size and Forecast By Product
10.5.3. Market Size and Forecast By End User
10.6. Argentina Sleep Apnea Therapeutic Devices Market Outlook
10.6.1. Market Size By Value
10.6.2. Market Size and Forecast By Product
10.6.3. Market Size and Forecast By End User
10.7. Columbia Sleep Apnea Therapeutic Devices Market Outlook
10.7.1. Market Size By Value
10.7.2. Market Size and Forecast By Product
10.7.3. Market Size and Forecast By End User
11. Middle East & Africa Sleep Apnea Therapeutic Devices Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Product
11.4. Market Size and Forecast, By End User
11.5. UAE Sleep Apnea Therapeutic Devices Market Outlook
11.5.1. Market Size By Value
11.5.2. Market Size and Forecast By Product
11.5.3. Market Size and Forecast By End User
11.6. Saudi Arabia Sleep Apnea Therapeutic Devices Market Outlook
11.6.1. Market Size By Value
11.6.2. Market Size and Forecast By Product
11.6.3. Market Size and Forecast By End User
11.7. South Africa Sleep Apnea Therapeutic Devices Market Outlook
11.7.1. Market Size By Value
11.7.2. Market Size and Forecast By Product
11.7.3. Market Size and Forecast By End User
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Porter's Five Forces
12.4. Company Profile
12.4.1. ResMed Inc.
12.4.1.1. Company Snapshot
12.4.1.2. Company Overview
12.4.1.3. Financial Highlights
12.4.1.4. Geographic Insights
12.4.1.5. Business Segment & Performance
12.4.1.6. Product Portfolio
12.4.1.7. Key Executives
12.4.1.8. Strategic Moves & Developments
12.4.2. Fisher & Paykel Healthcare Corporation Limited
12.4.3. Koninklijke Philips N.V.
12.4.4. GE HealthCare Technologies, Inc.
12.4.5. BMC Medical Co Ltd
12.4.6. Invacare Corporation
12.4.7. Itamar Medical Ltd
12.4.8. Compumedics Ltd
12.4.9. Drive DeVilbiss Healthcare
12.4.10. Nihon Kohden Corporation
12.4.11. LivaNova, PLC
12.4.12. Airway Management Inc.,
12.4.13. Rotech Healthcare Inc
12.4.14. Nyxoah SA
12.4.15. Cardinal Health, Inc
12.4.16. Drägerwerk AG & Co. KGaA
12.4.17. Inspire Medical Systems, Inc.
12.4.18. SomnoMed Limited
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
14.3. Related Reports
15. Disclaimer
 

List of Figures
Figure 1: Global Sleep Apnea Therapeutic Devices Market Size (USD Million) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 5: Global Sleep Apnea Therapeutic Devices Market Share By Region (2022)
Figure 6: North America Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 7: North America Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 8: US Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 9: Canada Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 10: Mexico Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 11: Europe Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 12: Europe Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 13: Germany Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 14: UK Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 15: France Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 16: Italy Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 17: Spain Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 18: Russia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 19: Asia-Pacific Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 20: Asia-Pacific Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 21: China Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 22: Japan Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 23: India Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 24: Australia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 25: South Korea Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 26: South America Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 27: South America Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 28: Brazil Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 29: Argentina Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 30: Columbia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 31: Middle East & Africa Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 32: Middle East & Africa Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 33: UAE Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 34: Saudi Arabia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 35: South Africa Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 36: Competitive Dashboard of top 5 players, 2022
Figure 37: Porter's Five Forces of Global Sleep Apnea Therapeutic Devices Market

List of Table
Table 1 : Global Sleep Apnea Therapeutic Devices Market Snapshot, By Segmentation (2022 & 2028) (in USD Million)
Table 2 : Influencing Factors for Sleep Apnea Therapeutic Devices Market, 2022
Table 3: Top 10 Counties Economic Snapshot 2020
Table 4: Economic Snapshot of Other Prominent Countries 2020
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Sleep Apnea Therapeutic Devices Market Size and Forecast, By Geography (2017 to 2028F) (In USD Million)
Table 7 : Global Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 8 : Global Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 9 : North America Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 10 : North America Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 11 : United States Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 12 : United States Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 13 : Canada Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 14 : Canada Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 15 : Mexico Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 16 : Mexico Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 17 : Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 18 : Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 19 : Germany Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 20 : Germany Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 21 : United Kingdom Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 22 : United Kingdom Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 23 : France Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 24 : France Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 25 : Italy Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 26 : Italy Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 27 : Spain Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 28 : Spain Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 29 : Russia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 30 : Russia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 31 : Asia-Pacific Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 32 : Asia-Pacific Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 33 : China Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 34 : China Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 35 : Japan Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 36 : Japan Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 37 : India Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 38 : India Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 39 : Australia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 40 : Australia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 41 : South Korea Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 42 : South Korea Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 43 : South America Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 44 : South America Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 45 : Brazil Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 46 : Brazil Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 47 : Argentina Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 48 : Argentina Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 49 : Colombia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 50 : Colombia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 51 : Middle East & Africa Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 52 : Middle East & Africa Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 53 : United Arab Emirates Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 54 : United Arab Emirates Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 55 : Saudi Arabia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 56 : Saudi Arabia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 57 : South Africa Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 58 : South Africa Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)

　

ページTOPに戻る


　

Summary

Sleep apnea is a common yet often undiagnosed sleep disorder that affects millions of people worldwide. Characterized by pauses in breathing or shallow breaths during sleep, sleep apnea can have serious implications for overall health and well-being. Sleep apnea is a prevalent sleep disorder affecting millions of people worldwide, characterized by interrupted breathing during sleep. According to the National Sleep Foundation, 50–70 million people have ongoing sleep disorders, let alone in US. The most common sleep disorder is insomnia, which involves difficulty falling or staying asleep. Fortunately, advancements in medical technology have led to the development of various devices aimed at managing and treating sleep apnea. The sleep apnea devices industry has witnessed remarkable growth in recent years, driven by increasing awareness of sleep apnea, advancements in technology, and a growing understanding of the importance of quality sleep for overall health. As awareness of sleep apnea grows, so does the demand for effective solutions to improve sleep quality and overall well-being. The consumer landscape for sleep apnea devices reflects a diverse array of preferences, needs, and expectations. An increasing awareness of sleep apnea has empowered consumers to seek information about available devices. Consumers are more likely to make informed decisions when equipped with knowledge about the types of devices, their functionalities, and their potential benefits. The digital age has facilitated easy access to information. Consumers often turn to online platforms, forums, and reputable health websites to gather insights, read reviews, and educate themselves about sleep apnea devices before making a purchase. The comfort of the mask is a critical consideration for consumers using Positive Airway Pressure (PAP) devices. Manufacturers have responded by designing masks with various shapes, sizes, and materials to enhance user comfort and reduce feelings of claustrophobia. Consumer preferences also lean towards quieter devices. Manufacturers strive to develop sleep apnea devices with reduced noise levels, addressing a common concern for individuals who share sleeping spaces with partners. The consumer landscape reflects a growing preference for portable and travel-friendly sleep apnea devices. Compact designs and lightweight materials cater to the needs of individuals who lead active lifestyles or frequently travel. Consumers like devices that seamlessly integrate into the daily routine, requiring minimal adjustment and maintenance. This integration enhances compliance and contributes to the effectiveness of treatment.

According to the research report, “Global Sleep Apnea Devices Market Outlook, 2028” published by Bonafide Research, the market is anticipated to cross USD 12 Billion by 2028, increasing from USD 8.47 Billion in 2022. The market is expected to grow with more than 7% CAGR by 2023-28. The increasing prevalence of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increased awareness among the patient population in emerging nations are the primary drivers driving the market. Aging is a major element driving the growth of the sleep apnea device market. The elderly are particularly vulnerable to getting this illness. Furthermore, it was revealed that sleep disturbances are among the most difficult medical conditions to treat, affecting one out of every three persons at some point in their life. Sleep apnea is a potentially fatal sleep disorder that often goes misdiagnosed and untreated. Various government programs, however, are assisting OSA patients. In the United States, for example, the American Sleep Apnea Association (ASAA) is a non-profit organization that raises awareness of sleep apnea, strives to improve treatment, and fights for the interests of sleep apnea patients. In addition, manufacturers' increased product releases to fulfill the growing demand for innovative goods are likely to boost market growth. In August 2021, for example, ResMed announced a new sleep apnea machine in an attempt to fill the hole left by Philips' CPAP recall. Similarly, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea, unveiled O2Vent Optima in February 2021, a highly effective and more convenient alternative to CPAP therapy. Furthermore, numerous government organizations, including the American Sleep Association and the German Sleep Society, are launching awareness campaigns to improve the quality of life for persons suffering from complicated and chronic sleep disorders. The desire for early-stage diagnosis is likely to drive market revenue as consumers get more information about sleep problems and their health effects. Chronic insomnia is becoming more common as the number of older and obese persons grows. Furthermore, the growing number of individuals suffering from melancholy, chronic sickness, and anxiety is driving up demand for sleep apnea equipment. Furthermore, the development of such devices would aid in the targeting of high-insomnia burden areas in underdeveloped countries.

Based on the region, North America currently dominates the market for sleep apnea devices, and it is expected to continue during the forecast period.

Changing lifestyles, greater disposable income, the existence of well-known players, an obese population, an increase in the frequency of respiratory disorders, increased awareness of OSA, and favorable government initiatives are among the primary reasons driving growth. Philips Respironics, Somnetics International Inc., and ResMed are among the leading players in North America. These companies have a significant commercial presence and well-established supply and distribution systems throughout North America. The rising prevalence of sleep apnea due to many underlying disorders such as sadness and anxiety, technological improvements, and research-increasing product introductions, as well as the significant influence of COVID-19 lockdowns on Americans in the region, are expected to drive the market. Furthermore, the increasing prevalence of other health issues, including as obesity and heart disease, which are high-risk factors for sleep apnea, is predicted to contribute to market growth. Furthermore, various government agencies are launching public awareness campaigns to educate consumers and medical professionals about healthy sleeping habits. Furthermore, the market's leading players are investing heavily in the development of technologically efficient, effective, and simple-to-use gadgets. It has been found that changes in lifestyle habits frequently result in a variety of sleeping difficulties. Furthermore, increased consumption of tobacco, caffeine, and alcohol has an impact on an individual's sleep pattern. Furthermore, the increase in the number of sleep care centers in the region is likely to drive market expansion. GoPAPfree, for example, announced the launch of its new individualized oral appliance treatment equipment on February 9, 2021, which provides an efficient and acceptable alternative to CPAP therapy for obstructive sleep apnea with at-home shaping and implementation. The presence of various centers in North America, such as Carilion Clinic, Adam Moscovitch, Florida Lung, Asthma, and Sleep Specialists, Oregon Sleep Associates, and Sound Sleep Health, will further boost the region's growth.

On the basis of product types, the therapeutic devices segment is the highest contributor to the market and is expected to grow at a significant growth rate during the forecast period.

During the projected period, the therapeutic devices segment is expected to account for the majority of revenue. This is due to an increase in the number of patients seeking treatment in sleep clinics, including CPAP therapy, as well as the development of new digital technologies aimed at making therapy setup and night usage easier for patients while also assisting physicians in providing care more effectively. For example, on August 16, 2021, ResMed, a global innovator in digital health and sleep apnea treatment, launched AirSense 11, the company's next-generation Positive Airway Pressure (PAP) device designed to assist hundreds of millions of sleep apnea patients worldwide in establishing and maintaining treatment for managing and treating obstructive sleep apnea. The presence of a large undiagnosed population, as well as increased awareness among these patients, is resulting in higher diagnosis rates in both developed and developing countries. This is increasing demand in these countries for diagnostic devices like as polysomnography devices. Therapeutic devices include positive airway pressure (PAP) devices, oral devices, nasal devices, and chin straps. The therapeutic devices category dominated the whole market in terms of revenue share in 2019. Manufacturers of SA devices should expect profitable possibilities as a result of factors such as greater patient adherence to supportive treatment, increased availability of technologically improved equipment, an increase in the number of efforts by local governments, and increased awareness of these diseases. This is expected to boost expansion in the therapeutic devices category throughout the forecast period. However, due to the increasing prevalence of sleep apnea mask comorbidities and the increased use of Continuous Positive Airway Pressure (CPAP) machines for illness management, the use of sleep apnea masks is expanding. There are a variety of SA masks available, including nasal masks, nasal pillow masks, and full-face masks. Continuous Positive Airway Pressure (CPAP) masks are used to connect the SA patient to the CPAP machine. Every CPAP mask works in the same way, delivering air from the CPAP machine to the patient's airway via a hose. This avoids Obstructive Sleep Apnea by keeping the airway open during sleeping. The use of sleep apnea masks is expected to be influenced by technological developments in sleep apnea devices.

The home care settings & individuals segment is expected to dominate the global market by 2028 propelled by the accelerating adoption and introduction of user-friendly homecare sleep apnea devices, along with spreading awareness associated with home healthcare.

During the projected period, the increased usage of sleep apnea diagnostic and treatment devices for self-administration in home care settings is expected to boost the growth of this market segment. Home care sleep diagnostic technology is accurate for people with mild to severe sleep apnea. They are considered less obtrusive because they are utilized in a typical household atmosphere. Market suppliers are investing in the development of technologies for home sleep apnea diagnostics. Due to increased investments by leading market players, the home care settings/individuals sector is likely to gain a greater revenue share during the forecast period. For example, on October 3, 2022, Acurable, a UK-based medical device company, announced a USD 10.8 million Series A fundraising round headed by Kibo Ventures. The fund was co-led by Mundi Ventures, Comprador Holdings, and Kindred Capital. This financing will be used to accelerate the international expansion of AcuPebble SA100, the company's first home sleep-testing device for detecting and monitoring obstructive sleep apnea. Market participants are concentrating their efforts on introducing novel and portable gadgets for home usage among patients getting treatment for the illness. This, combined with an increased preference for home-based treatment of OSA, particularly in nations such as the United States, the United Kingdom, Germany, and Japan, is driving up demand for these devices in homecare and other settings. For example, GoPAPfree, a homecare provider of oral appliance therapy for sleep apnea, launched O2Vent OptimaI in February 2021, which is a highly effective and alternative therapy to CPAP therapy that can be utilized at home. This, together with sufficient reimbursement regulations that promote home usage of these devices, is further facilitating market expansion.

Market Drivers

• Increasing Prevalence of Sleep Apnea: The rising prevalence of sleep apnea worldwide is a significant driver for the sleep apnea devices market. Factors such as obesity, sedentary lifestyles, and an aging population contribute to the growing incidence of sleep apnea. As awareness of sleep disorders increases among both healthcare professionals and the general population, the demand for diagnostic and therapeutic devices for sleep apnea is expected to rise.

• Technological Advancements in Sleep Apnea Devices: Advances in technology have led to the development of more efficient and user-friendly sleep apnea devices. Innovations in device design, such as the use of compact and wearable devices, improved mask technologies, and the incorporation of data connectivity for remote monitoring, contribute to better patient compliance and treatment outcomes. Technological advancements are likely to drive market growth as healthcare providers seek more effective and patient-friendly solutions.

Market Challenges

• Limited Patient Compliance: Continuous Positive Airway Pressure (CPAP) therapy, which is a common treatment for sleep apnea, may be perceived as uncomfortable by some patients, leading to poor adherence. Addressing issues related to patient comfort, education, and support is crucial to improving compliance rates and ensuring the effectiveness of sleep apnea treatments.

• High Cost of Sleep Apnea Devices: The cost of sleep apnea devices, particularly advanced devices with sophisticated features, can be a barrier to widespread adoption. Affordability is a significant concern, particularly in regions with limited healthcare resources. Manufacturers and healthcare providers face the challenge of balancing the development of advanced technologies with the need to make these devices accessible and cost-effective for a broader patient population.

Market Trends

• Home Sleep Testing (HST): There is a growing trend toward home sleep testing as an alternative to traditional in-laboratory sleep studies. Home sleep testing allows for more convenient and cost-effective diagnosis of sleep apnea, contributing to increased patient access to testing. This trend aligns with the broader movement towards decentralized healthcare and patient-centric solutions.

• Integration of Artificial Intelligence (AI) and Data Analytics: The integration of AI and data analytics in sleep apnea devices is a notable trend. Smart devices can collect and analyze data related to sleep patterns and treatment adherence, providing valuable insights for both patients and healthcare providers. AI algorithms can enhance the personalization of treatment plans, leading to more effective interventions and improved patient outcomes.

• Telemedicine and Remote Monitoring: The trend toward telemedicine and remote patient monitoring has been accelerated, especially in the context of sleep apnea. Telemedicine allows for virtual consultations, remote monitoring of sleep patterns, and adjustments to treatment plans without the need for frequent in-person visits. This trend has become more prominent, particularly in situations where access to healthcare facilities is challenging.

Covid-19 Impacts

The pandemic has disrupted global supply chains, affecting the manufacturing and distribution of medical devices, including sleep apnea devices. Lockdowns, travel restrictions, and changes in demand for healthcare resources have led to challenges in the production and delivery of these devices. Due to the pandemic, individuals have postponed or avoided seeking medical attention for non-urgent health issues, including sleep-related disorders. This delay in diagnosis and treatment could impact the demand for sleep apnea devices, as patients not have been identified and prescribed appropriate therapies during the height of the pandemic. The pandemic has accelerated the adoption of telemedicine and remote monitoring solutions across various healthcare sectors. Sleep apnea patients, in particular, have sought virtual consultations and remote monitoring options to avoid in-person visits to healthcare facilities. This trend could influence the development and adoption of sleep apnea devices with enhanced connectivity features. Economic challenges resulting from the pandemic have affected individuals' ability to afford healthcare services and devices. This economic impact could influence the purchasing decisions of sleep apnea patients, potentially leading to shifts in demand for different types of devices or preferences for more cost-effective solutions. The heightened awareness of respiratory health during the COVID-19 pandemic has increased attention to sleep-related breathing disorders. Healthcare providers and patients alike are more attuned to symptoms of sleep apnea, potentially driving increased diagnoses and treatment once healthcare services returned to a more normalized state. With the widespread adoption of remote work during the pandemic, changes in work schedules and lifestyles have influenced sleep patterns. These shifts could impact the prevalence of sleep disorders, including sleep apnea, and subsequently, the demand for diagnostic and therapeutic devices.

Competitive Landscape

The key players are constantly focusing on innovative product development strategies to gain a competitive edge and expand their business footprints. The companies are devising merger & acquisitions and partnership strategies to expand their product offering and serve the growing customer pool. For instance, in February 2021, Nyxoah SA and Vanderbilt University entered a strategic partnership to develop innovative neurostimulation solutions for treating OSA. Prominent companies in this market include well-established, financially stable manufacturers of diagnostic and therapeutic sleep apnea devices. These sleep apnea companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent sleep apnea companies in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

Key Developments

• In November 2022, ResMed and Alphabet's life science offshoot Verily announced the formation of Primasun, an end-to-end solution to help employers and healthcare providers identify populations at risk for complex sleep disorders.

• In October 2022, Airway Management, manufacturer of the most globally researched custom oral appliances, announced the launch of flexTAP, a premium lab-made oral appliance designed to treat patients with snoring and mild to moderate obstructive sleep apnea.

• In September 2022, GE Healthcare and Wayra teamed up with seven health tech start-ups to accelerate the digital transformation of healthcare across Europe, the Middle East, and Africa.

• In February 2022, the TCM5 Flex Transcutaneous Monitor has been added to Compumedics' already comprehensive line of sleep diagnostic products due to collaboration with Radiometer Pacific. Compumedics is now the TCM 5 Flex's authorized distributor in Australia and New Zealand.

• In 2022, Fisher & Paykel Healthcare (New Zealand) launched Evora Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment in US.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global Sleep Apnea Devices market with its value and forecast along with its segments
• Region & Country-wise Sleep Apnea Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions & Countries covered in the report

• North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
• Asia-Pacific (China, Japan, India, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle-East & Africa (UAE, Saudi Arabia, South Africa)

By Product:

• Positive Airway Pressure (PAP) Devices
• Adaptive Servo-Ventilation (ASV)
• Airway Clearance Systems
• Oxygen Delivery Products
• Oral Appliances
• Others

By End User:

• Home care Settings & Individuals
• Sleep laboratories & Hospitals



The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Sleep Apnea Therapeutic Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.






""
"
***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Covid-19 Effect
2.5. Supply chain Analysis
2.6. Policy & Regulatory Framework
2.7. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Sleep Apnea Therapeutic Devices Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Product
6.5. Market Size and Forecast, By End User
7. North America Sleep Apnea Therapeutic Devices Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Product
7.4. Market Size and Forecast, By End User
7.5. United States Sleep Apnea Therapeutic Devices Market Outlook
7.5.1. Market Size By Value
7.5.2. Market Size and Forecast By Product
7.5.3. Market Size and Forecast By End User
7.6. Canada Sleep Apnea Therapeutic Devices Market Outlook
7.6.1. Market Size By Value
7.6.2. Market Size and Forecast By Product
7.6.3. Market Size and Forecast By End User
7.7. Mexico Sleep Apnea Therapeutic Devices Market Outlook
7.7.1. Market Size By Value
7.7.2. Market Size and Forecast By Product
7.7.3. Market Size and Forecast By End User
8. Europe Sleep Apnea Therapeutic Devices Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Product
8.4. Market Size and Forecast, By End User
8.5. Germany Sleep Apnea Therapeutic Devices Market Outlook
8.5.1. Market Size By Value
8.5.2. Market Size and Forecast By Product
8.5.3. Market Size and Forecast By End User
8.6. United Kingdom Sleep Apnea Therapeutic Devices Market Outlook
8.6.1. Market Size By Value
8.6.2. Market Size and Forecast By Product
8.6.3. Market Size and Forecast By End User
8.7. France Sleep Apnea Therapeutic Devices Market Outlook
8.7.1. Market Size By Value
8.7.2. Market Size and Forecast By Product
8.7.3. Market Size and Forecast By End User
8.8. Italy Sleep Apnea Therapeutic Devices Market Outlook
8.8.1. Market Size By Value
8.8.2. Market Size and Forecast By Product
8.8.3. Market Size and Forecast By End User
8.9. Spain Sleep Apnea Therapeutic Devices Market Outlook
8.9.1. Market Size By Value
8.9.2. Market Size and Forecast By Product
8.9.3. Market Size and Forecast By End User
8.10. Russia Sleep Apnea Therapeutic Devices Market Outlook
8.10.1. Market Size By Value
8.10.2. Market Size and Forecast By Product
8.10.3. Market Size and Forecast By End User
9. Asia-Pacific Sleep Apnea Therapeutic Devices Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Product
9.4. Market Size and Forecast, By End User
9.5. China Sleep Apnea Therapeutic Devices Market Outlook
9.5.1. Market Size By Value
9.5.2. Market Size and Forecast By Product
9.5.3. Market Size and Forecast By End User
9.6. Japan Sleep Apnea Therapeutic Devices Market Outlook
9.6.1. Market Size By Value
9.6.2. Market Size and Forecast By Product
9.6.3. Market Size and Forecast By End User
9.7. India Sleep Apnea Therapeutic Devices Market Outlook
9.7.1. Market Size By Value
9.7.2. Market Size and Forecast By Product
9.7.3. Market Size and Forecast By End User
9.8. Australia Sleep Apnea Therapeutic Devices Market Outlook
9.8.1. Market Size By Value
9.8.2. Market Size and Forecast By Product
9.8.3. Market Size and Forecast By End User
9.9. South Korea Sleep Apnea Therapeutic Devices Market Outlook
9.9.1. Market Size By Value
9.9.2. Market Size and Forecast By Product
9.9.3. Market Size and Forecast By End User
10. South America Sleep Apnea Therapeutic Devices Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Product
10.4. Market Size and Forecast, By End User
10.5. Brazil Sleep Apnea Therapeutic Devices Market Outlook
10.5.1. Market Size By Value
10.5.2. Market Size and Forecast By Product
10.5.3. Market Size and Forecast By End User
10.6. Argentina Sleep Apnea Therapeutic Devices Market Outlook
10.6.1. Market Size By Value
10.6.2. Market Size and Forecast By Product
10.6.3. Market Size and Forecast By End User
10.7. Columbia Sleep Apnea Therapeutic Devices Market Outlook
10.7.1. Market Size By Value
10.7.2. Market Size and Forecast By Product
10.7.3. Market Size and Forecast By End User
11. Middle East & Africa Sleep Apnea Therapeutic Devices Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Product
11.4. Market Size and Forecast, By End User
11.5. UAE Sleep Apnea Therapeutic Devices Market Outlook
11.5.1. Market Size By Value
11.5.2. Market Size and Forecast By Product
11.5.3. Market Size and Forecast By End User
11.6. Saudi Arabia Sleep Apnea Therapeutic Devices Market Outlook
11.6.1. Market Size By Value
11.6.2. Market Size and Forecast By Product
11.6.3. Market Size and Forecast By End User
11.7. South Africa Sleep Apnea Therapeutic Devices Market Outlook
11.7.1. Market Size By Value
11.7.2. Market Size and Forecast By Product
11.7.3. Market Size and Forecast By End User
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Porter's Five Forces
12.4. Company Profile
12.4.1. ResMed Inc.
12.4.1.1. Company Snapshot
12.4.1.2. Company Overview
12.4.1.3. Financial Highlights
12.4.1.4. Geographic Insights
12.4.1.5. Business Segment & Performance
12.4.1.6. Product Portfolio
12.4.1.7. Key Executives
12.4.1.8. Strategic Moves & Developments
12.4.2. Fisher & Paykel Healthcare Corporation Limited
12.4.3. Koninklijke Philips N.V.
12.4.4. GE HealthCare Technologies, Inc.
12.4.5. BMC Medical Co Ltd
12.4.6. Invacare Corporation
12.4.7. Itamar Medical Ltd
12.4.8. Compumedics Ltd
12.4.9. Drive DeVilbiss Healthcare
12.4.10. Nihon Kohden Corporation
12.4.11. LivaNova, PLC
12.4.12. Airway Management Inc.,
12.4.13. Rotech Healthcare Inc
12.4.14. Nyxoah SA
12.4.15. Cardinal Health, Inc
12.4.16. Drägerwerk AG & Co. KGaA
12.4.17. Inspire Medical Systems, Inc.
12.4.18. SomnoMed Limited
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
14.3. Related Reports
15. Disclaimer
 

List of Figures
Figure 1: Global Sleep Apnea Therapeutic Devices Market Size (USD Million) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 5: Global Sleep Apnea Therapeutic Devices Market Share By Region (2022)
Figure 6: North America Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 7: North America Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 8: US Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 9: Canada Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 10: Mexico Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 11: Europe Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 12: Europe Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 13: Germany Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 14: UK Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 15: France Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 16: Italy Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 17: Spain Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 18: Russia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 19: Asia-Pacific Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 20: Asia-Pacific Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 21: China Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 22: Japan Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 23: India Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 24: Australia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 25: South Korea Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 26: South America Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 27: South America Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 28: Brazil Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 29: Argentina Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 30: Columbia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 31: Middle East & Africa Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 32: Middle East & Africa Sleep Apnea Therapeutic Devices Market Share By Country (2022)
Figure 33: UAE Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 34: Saudi Arabia Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 35: South Africa Sleep Apnea Therapeutic Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 36: Competitive Dashboard of top 5 players, 2022
Figure 37: Porter's Five Forces of Global Sleep Apnea Therapeutic Devices Market

List of Table
Table 1 : Global Sleep Apnea Therapeutic Devices Market Snapshot, By Segmentation (2022 & 2028) (in USD Million)
Table 2 : Influencing Factors for Sleep Apnea Therapeutic Devices Market, 2022
Table 3: Top 10 Counties Economic Snapshot 2020
Table 4: Economic Snapshot of Other Prominent Countries 2020
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Sleep Apnea Therapeutic Devices Market Size and Forecast, By Geography (2017 to 2028F) (In USD Million)
Table 7 : Global Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 8 : Global Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 9 : North America Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 10 : North America Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 11 : United States Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 12 : United States Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 13 : Canada Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 14 : Canada Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 15 : Mexico Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 16 : Mexico Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 17 : Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 18 : Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 19 : Germany Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 20 : Germany Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 21 : United Kingdom Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 22 : United Kingdom Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 23 : France Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 24 : France Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 25 : Italy Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 26 : Italy Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 27 : Spain Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 28 : Spain Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 29 : Russia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 30 : Russia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 31 : Asia-Pacific Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 32 : Asia-Pacific Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 33 : China Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 34 : China Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 35 : Japan Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 36 : Japan Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 37 : India Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 38 : India Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 39 : Australia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 40 : Australia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 41 : South Korea Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 42 : South Korea Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 43 : South America Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 44 : South America Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 45 : Brazil Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 46 : Brazil Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 47 : Argentina Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 48 : Argentina Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 49 : Colombia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 50 : Colombia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 51 : Middle East & Africa Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Million)
Table 52 : Middle East & Africa Sleep Apnea Therapeutic Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Million)
Table 53 : United Arab Emirates Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 54 : United Arab Emirates Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 55 : Saudi Arabia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 56 : Saudi Arabia Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)
Table 57 : South Africa Sleep Apnea Therapeutic Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Million)
Table 58 : South Africa Sleep Apnea Therapeutic Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Million)

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（環境・エネルギー）の最新刊レポート

Bonafide Research & Marketing Pvt. Ltd.社のLifescience 分野での最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート


よくあるご質問


Bonafide Research & Marketing Pvt. Ltd.社はどのような調査会社ですか?


Bonafide Research & Marketing Pvt. Ltd.は、最新の経済、人口統計、貿易、市場データを提供する市場調査・コンサルティング会社です。調査レポート、カスタムレポート、コ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23　10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.